Farzad Azimpour is a health technology designer and cardiologist serving as Chief Medical Officer at Myia Health, Adjunct Professor of Medicine at Stanford University School of Medicine, and Assistant Director (Design) at Stanford Byers Center for Biodesign.
In partnership with the American College of Cardiology, Dr. Azimpour leads cardiovascular and medical design operations at MYIA Labs, developing a computational platform for new embodiments of precision medicine decision-making.
Academically, he teaches and facilitates design strategy for Stanford Biodesign fellows and students. He co-directed the inaugural Stanford Medicine course titled MED267 on design for the human experience in medicine, with Dr. Abraham Verghese and colleagues. He is also a contributor to the Stanford Presence 5 research team, designing the future of human clinical interactions in an increasingly digital ecosystem.
Prior to his current roles, Dr. Azimpour served as Director of Health at the global design and innovation firm IDEO. He was the 2014 St. Jude Medical and Dean's Innovation Fellow at Stanford Biodesign after completing his clinical training in medicine and cardiology at Cleveland Clinic and the University of Minnesota's Lillehei Heart Institute, respectively. He served as Chief Cardiology Fellow and was awarded an NIH fellowship in advanced cardiovascular technologies where he ran feasibility studies on acoustic detection of coronary artery stenosis, augmented vascular access, and implantable cardio-embolic stroke protection systems.
Dr. Azimpour holds a Bachelor's degree in Biological Sciences from The University of Texas at Austin, an MD from The University of Texas Medical Branch, and a post-doctoral designation in Biodesign from Stanford University School of Medicine.
He is a recipient of Phi Beta Kappa distinction and the Arnold P. Gold Foundation Humanism in Medicine Award.